a Cohort Study (Gut Microbiota and HCC)

Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma

NCT05759858 ·Status: RECRUITING

The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

NCT02416635 ·Status: COMPLETED

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

NCT04152356 ·Status: UNKNOWN

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

NCT05609695 ·Status: UNKNOWN

The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

NCT05573217 ·Status: UNKNOWN

Primary Hepatobiliary Cancer Cohort of Central China

NCT05520801 ·Status: RECRUITING

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

NCT03672305 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

NCT05242237 ·Status: UNKNOWN

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

NCT07117279 ·Status: NOT_YET_RECRUITING

Circulating Tumor Cells for Hepatocellular Carcinoma

NCT01930383 ·Status: UNKNOWN

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

NCT06643533 ·Status: NOT_YET_RECRUITING

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

NCT04163237 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC

NCT06818097 ·Status: COMPLETED

A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

NCT01758679 ·Status: UNKNOWN ·Phase: PHASE4

Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma

NCT03668158 ·Status: UNKNOWN

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

NCT06881433 ·Status: COMPLETED

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

NCT05520788 ·Status: RECRUITING

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

NCT03893695 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

NCT05233358 ·Status: UNKNOWN ·Phase: NA

NGS as the First-line Treatment in Advanced Biliary Tract Cancer

NCT04172402 ·Status: COMPLETED ·Phase: PHASE2

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

NCT05420922 ·Status: UNKNOWN

A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

NCT05371873 ·Status: UNKNOWN

Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy

NCT05620004 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular Carcinoma

NCT06715072 ·Status: NOT_YET_RECRUITING

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

NCT05292443 ·Status: WITHDRAWN